<DOC>
	<DOCNO>NCT00240422</DOCNO>
	<brief_summary>The primary objective evaluate effect 9 week treatment either telmisartan ramipril NO bioavailability renal vasculature , measure renal plasma flow ( RPF ) response NG-monomethyl-L-arginine ( LNMMA ) infusion .</brief_summary>
	<brief_title>Trial Compare Effects Either Telmisartan ( 40-80 mg PO Once Daily ) Ramipril ( 5-10 mg PO Once Daily ) Renal Endothelial Dysfunction Hypertensive Patients With Type 2 Diabetes</brief_title>
	<detailed_description>This study design randomise , double-blind , double-dummy , parallel group hypertensive patient type 2 diabetes normo- microalbuminuria treatment period 9 week . After 4 week Run-in period , patient randomise one treatment group receive either Telmisartan 40 - 80 mg Ramipril 5 - 10 mg . The treatment regimen force titration lower dose give 3 week high dose give rest treatment period sum 9 week treatment . During treatment period , 3 visit investigator schedule order control blood pressure , renal function parameter safety . In addition , parameter endothelial function renal vasculature , base nephrological clearance investigation provocation L-NMMA measure baseline 9 week treatment . Study Hypothesis : Due exploratory nature trial , primary objective evaluate effect RPF response L-NMMA infusion baseline 9 week therapy either telmisartan 80 mg ramipril 10 mg plan addressed test prespecified hypothesis . Comparison ( ) : The change RPF baseline ( Visit 4 ) end treatment ( Visit 7 ) response L-NMMA infusion calculate change pre L-NMMA infusion ( S1 ) end L-NMMA infusion ( S2 ) . A comparison treatment group make use analysis covariance ( ANCOVA ) pool centre treatment include main effect RPF ( response L NMMA infusion ) baseline covariate . The treatment group difference , adjust factor model , present correspond 95 % confidence interval ( CI ) test statistical significance . The model also use provide analysis result within treatment group change .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Hypertensive patient age 3080 year type 2 diabetes , normo microalbuminuria , GFR &gt; 80 mL/min ( CockroftGault ) None</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>